TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Orifarm Generics A/S
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,720,538
|
3,224,465
|
2,937,013 |
| Earnings before taxes |
122,338
|
121,051
|
98,428 |
| Total assets |
1,651,904
|
2,084,970
|
1,904,158 |
| Current assets |
1,560,952
|
2,009,235
|
1,837,171 |
| Current liabilities |
751,256
|
1,322,567
|
1,278,278 |
| Equity capital |
880,521
|
746,036
|
611,117 |
| - share capital |
1,588
|
1,508
|
1,416 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
53.3%
|
35.8%
|
32.1% |
| Turnover per employee |
24,804
|
21,496
|
19,580 |
| Profit as a percentage of turnover |
3.3%
|
3.8%
|
3.4% |
| Return on assets (ROA) | |||
| Current ratio |
207.8%
|
151.9%
|
143.7% |
| Return on equity (ROE) |
13.9%
|
16.2%
|
16.1% |
| Change turnover |
325,643
|
95,166
|
449,412 |
| Change turnover % |
10%
|
3%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.